Get started
Author

Salwa Shihadeh Saadeh

Observed names: S. Saadeh, S.S. Saadeh, Salwa S Saadeh, Salwa S. Saadeh, Salwa Saadeh
Observed institutions: University of Jordan, Mayo Clinic, Jordan University of Science and Technology, King Hussein Cancer Center, King Abdullah University Hospital, Instituto de Investigación Biomédica de Salamanca, Instituto Nacional de Câncer - INCA, Newcastle University
ORCID: 0000-0002-1052-9093
Observed ORCID: 0000-0002-1052-9093
OpenAlex ID: A5072097404
The Impact of Treatment of Portopulmonary Hypertension on Survival Following Liver Transplantation
2007 · M. Ashfaq, S. Chinnakotla, et al. · American Journal of Transplantation · 188
PDF
The prevalence of Behçet's disease in the north of Jordan: a hospital-based epidemiological survey.
2018 · Wafa Y Madanat, Khaldoon M Alawneh, et al. · PubMed · 26
Clinical Course and Complications of Catheter and Non-Catheter-Related Upper Extremity Deep Vein Thrombosis in Patients with Cancer
2018 · Asem Mansour, Salwa S. Saadeh, et al. · Clinical and Applied Thrombosis/Hemostasis · 23
Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present state
2018 · Salwa S. Saadeh, Mark R. Litzow · Expert Review of Hematology · 23
Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents
2020 · Hikmat Abdel-Razeq, Salwa S. Saadeh, et al. · Therapeutic Advances in Medical Oncology · 20
PDF
Breast Cancer in the Arab World
2022 · Salwa Saadeh, Hikmat Abdel-Razeq · Springer eBooks · 18
PDF
The Application of Current Proposed Venous Thromboembolism Risk Assessment Model for Ambulatory Patients With Cancer
2017 · Hikmat Abdel-Razeq, Asem Mansour, et al. · Clinical and Applied Thrombosis/Hemostasis · 18
PDF
Implementation of a patient blood management program in hematopoietic stem cell transplantation (Editorial, p. 2763)
2019 · Matthew A. Warner, Nilesh S. Jambhekar, et al. · Transfusion · 17
Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience
2022 · Sachi Singhal, Salwa S. Saadeh, et al. · Transplantation and Cellular Therapy · 16
Therapy of posttransplant poor graft function with eltrombopag
2020 · Khalid Halahleh, Robert Peter Gale, et al. · Bone Marrow Transplantation · 15
PDF
Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis
2014 · Khaldoon M. Alawneh, Mahmoud H. Ayesh, et al. · Biologics · 15
PDF
Resolution of intracardiac and pulmonary thrombi without anticoagulation in a patient with Behçet's disease: a case report.
2013 · Shaher M Samrah, Salwa S Saadeh, et al. · PubMed · 12
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy
2018 · Omar A. Alkharabsheh, Salwa S. Saadeh, et al. · Annals of Hematology · 11
From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer
2017 · Hikmat Abdel-Razeq, Lina Marei, et al. · Breast Cancer Research and Treatment · 10
Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients
2018 · Hikmat Abdel-Razeq, Salwa Saadeh, et al. · OncoTargets and Therapy · 9
PDF
Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes
2018 · Omar Alkharabsheh, Salwa S. Saadeh, et al. · American Journal of Hematology · 2
PDF
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS
2018 · Omar Alkharabsheh, Aref Al‐Kali, et al. · American Journal of Hematology · 2
PDF
Persistent microbiome dysbiosis following hematopoietic cell transplantation: Gut GvHD as the most severe manifestation of microbial disruption
2025 · Hasan Hashem, Muna Al Zughbieh, et al. · Blood · 1
PDF
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of Immunosuppression
2025 · Mohammad Ma'koseh, Zaid Abdel Rahman, et al. · Clinical Lymphoma Myeloma & Leukemia · 1
Characteristics and Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma: A 14-Year Experience in a Limited Resource Setting
2024 · Abeer Yaseen, Mohammad Ma'koseh, et al. · Blood · 1
1449P Aggressiveness of cancer care at end of life in patients with metastatic breast cancer: A regional perspective
2021 · M.K. Abunasser, S.S. Saadeh, et al. · Annals of Oncology · 1
The use of intravenous ferric carboxymaltose without erythropoiesis-stimulating agents in the treatment of anemia in cancer patients undergoing chemotherapy with or without radiotherapy
2019 · H. Abdel-Razeq, S.S. Saadeh, et al. · Annals of Oncology · 1
Outcomes of allogeneic hematopoietic cell transplantation in patients with carbapenem-resistant organisms infection: a propensity score-matched analysis
2026 · Abeer Yaseen, Teeba Mubaydeen, et al. · Frontiers in Transplantation
PDF
Real-world outcomes of multiple myeloma in a resource-constrained setting: a 14-year experience from a tertiary cancer center in Jordan
2025 · Abeer Yaseen, Mohammad Ma'koseh, et al. · Blood Global Hematology
The Impact of Carbapenem-Resistant Enterobacteriaceae (CRE) Infection on Outcomes of Allogeneic Hematopoietic Stem Cell Transplant: A Propensity Score Analysis
2025 · Zaid Abdel Rahman, Abeer Yaseen, et al. · Transplantation and Cellular Therapy
Works count: 38
Citation count: 430
H-index: 12
I10-index: 14
Year
Topic
Type